Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01197781 · ClinicalTrials.gov registry record · Phase 1
Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers
A Phase 1 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 1
- Development phase
- 15
- Enrollment target
NCT01197781 is a Phase 1 study that has completed, run by AstraZeneca. The registered enrollment target is 15 participants.
The verdict
NCT01197781, a Phase 1 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 15 participants
- Enrollment target
Study Summary
This Study evaluates the possible drug interaction between FosD and verapamil when taken together.
Interventions
- DRUG Verapamil
- DRUG FOSTAMATIN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01197781
The ClinicalTrials.gov registry entry for NCT01197781 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Verapamil is the first listed.
NCT01197781 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01197781 about?
NCT01197781 is a clinical study titled "Evaluation of the Drug-drug Interaction Between FosD and Verapamil When Taken Together in Healthy Volunteers". This Study evaluates the possible drug interaction between FosD and verapamil when taken together.
What is the current status of trial NCT01197781?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 15 participants. The study started on 2010-09. Estimated completion is 2010-10.
What interventions are being tested in trial NCT01197781?
The interventions under investigation include: Verapamil (DRUG), FOSTAMATIN (DRUG).
Who is sponsoring clinical trial NCT01197781?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.